Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Recurrence × Cisplatin × Clear all

Phase

Status

Sponsor Class

OTHER 24 INDUSTRY 14 OTHER_GOV 1 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Lung Neoplasms 5 Esophageal Neoplasms 5 Uterine Cervical Neoplasms 3 Nasopharyngeal Carcinoma 3 Esophageal Squamous Cell Carcinoma 3 Breast Neoplasms 3 Neoplasms, Germ Cell and Embryonal 2 Nasopharyngeal Neoplasms 2 Carcinoma, Squamous Cell 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Oesophagogastric Cancer 1 Neoplasms, Squamous Cell 1 Neoplasm Metastasis 1 Mesothelioma, Malignant 1 Locally Advanced Cervical Cancer 1 Head and Neck Neoplasms 1 Gastro-enteropancreatic neuroendocrine tumor 1 Gallbladder Neoplasms 1 Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement 1 Endometrial Neoplasms 1 EGFR Positive Non-small Cell Lung Cancer 1 Adenocarcinoma of Lung 1 Acquired Immunodeficiency Syndrome 1

Interventions

Surgical Procedures, Operative 2 Dexamethasone 2 temoporfin 1 pomalidomide 1 pembrolizumab 1 nimotuzumab 1 liposomal doxorubicin 1 ledipasvir 1 ibrutinib 1 Vinorelbine 1 Tomography, X-Ray Computed 1 Thalidomide 1 Sofosbuvir 1 Rituximab 1 Ribavirin 1 Radiotherapy 1 Radiation 1 Paclitaxel 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Mitoxantrone 1 Mastectomy 1 Irinotecan 1 Immunotherapy, Adoptive 1 Hematologic Tests 1 Drug Therapy 1 Docetaxel 1 Diagnostic Imaging 1 Dermoscopy 1 Cyclophosphamide 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06670911 2025-02-24

ACCESS-I

Instituto Nacional de Cancer, Brazil

Phase 2 Recruiting

Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡